Doxorubicin resistance in a small cell lung cancer cell line can be abolished by siRNA down-regulation of cox 1
Multidrug resistance (MDR) in small cell lung cancer is one of the major causes of failures of chemotherapy. MDR is a means of protection of tumor cells against chemotherapeutic drugs. Although the molecular basis of MDR is not fully understood, genes involved in apoptosis may be mutated. Recent fin...
Main Author: | Aryal, Pratik |
---|---|
Other Authors: | Vann, Carolyn N. |
Format: | Others |
Published: |
2011
|
Subjects: | |
Online Access: | http://cardinalscholar.bsu.edu/handle/handle/188277 http://liblink.bsu.edu/uhtbin/catkey/1371682 |
Similar Items
-
Abolishing multidrug resistance in cultured lung cancer cells with RNA interference
by: Prajapati, Kamal
Published: (2011) -
Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature
by: Alessandra Pannunzio, et al.
Published: (2018-10-01) -
Targeted Delivery of siRNA with pH-Responsive Hybrid Gold Nanostars for Cancer Treatment
by: Hongyan Zhu, et al.
Published: (2017-09-01) -
Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis
by: Dai P, et al.
Published: (2018-02-01) -
Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line
by: Osman Abdel-Moneim M, et al.
Published: (2012-11-01)